Navigation Links
Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709

High Concentrations Reached in Key Lung Compartments

REINACH and BASEL, Switzerland, March 29, 2007 /PRNewswire-FirstCall/ -- Arpida Ltd. today announced promising results of "first-in-man" studies with AR-709. These radiolabelled Human Microdose studies included a total of 19 healthy male volunteers.

This groundbreaking study is the first ever using Microdosing for the determination of drug concentrations in lung compartments. The results showed that AR-709 achieves high concentrations in bronchial mucosa (BM), epithelial lining fluid (ELF) and alveolar macrophages (AM), the three key compartments of the lungs where pathogens can reside and replicate. Moreover, the results of the studies show that AR-709 exhibited a large volume of distribution and a long half life in man. Oral bioavailability was potentially low but this could be due to the low dose, poor absorption or extensive metabolism.

The studies were conducted at Hammersmith Medicines Research Ltd (London, UK) under MHRA regulatory authorisation and were coordinated by Xceleron Ltd (York, UK), the exploratory clinical development specialist and world leader in the field of Human Microdosing.

Dr Sergio Lociuro, Head of Research of Arpida Ltd. commented "I am very pleased with the results of this first human trial with AR-709. They clearly show that the compound distributes well throughout the body and more importantly in the lungs. In a substantial number of cases, community-acquired respiratory tract infections, caused by S. pneumoniae, require hospitalisation and intravenous therapy. AR-709 appears to have the necessary characteristics to eradicate the microorganisms that can result in serious infections. For cases not requiring hospitalisation and/or to accelerate patient discharge from the hospital, targeted delivery, e.g. via inhalation, could provide a valid and promising alternative to administration via the oral route. Altho
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Arpida adds novel antibiotic AR-2474 to its preclinical pipeline
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Arpida Announces Promising Results First Man Studies With
(Date:11/26/2014)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... of Regulus, will present a company overview at the ... the New York Palace Hotel on Wednesday, December 3, ... webcast at the time of the presentation and can ...
(Date:11/26/2014)... 26, 2014  BioScrip ® , Inc. (NASDAQ: BIOS ... Chief Executive Officer, will present at the Bank of America Merrill ... , , Date: , , , Wednesday, December 3, 2014 , ... , , , , Location: , , , Boca Raton ... BioScrip, Inc. BioScrip, Inc. is a leading ...
(Date:11/26/2014)... The medical magnetic resonance imaging (MRI) ... with world market revenues for 2013 at $5.1 ... types of medical imaging have led to improvements ... conditions in children and adults, each imaging procedure ... Medical Imaging Markets , analyzes the current and ...
Breaking Medicine Technology:Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3
... , , ... that it will provide H1N1 flu vaccinations at select ... beginning Tuesday, December 29. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090129/NE64371LOGO ... everyone to get an H1N1 flu vaccine. Massachusetts, ...
... , , , SEATTLE, Dec. 28 Cell Therapeutics, Inc. (CTI) ... CTI,s Board of Directors (the "Board of Directors") approved and adopted ... stock purchase right will be distributed for each common share held ... the rights are not exercisable, and are attached to and trade ...
Cached Medicine Technology:CVS/pharmacy to Provide H1N1 Vaccinations in Massachusetts, Virginia and Orange County, California 2Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 2Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 3Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 4
(Date:11/27/2014)... (PRWEB) November 27, 2014 In ... individuals allot to sleep has lessened, and due ... laptops, the quality of sleep has eroded. According ... asleep on the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). ... productivity index by an incalculable amount, leading not ...
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. ... to acquire a second language, new research suggests. But anyone ... gain a brain boost, the small study finds. ... study co-author Ping Li, co-director of the Center for Brain, ... more interesting, Li said, that "the brain networks of the ...
(Date:11/27/2014)... The founders of VIM & VIGR, a ... functioning compression socks, are proud to announce the debut of ... Gradient Pressure (TM) knitting technology that is designed to increase ... commitment to adding flair and style to a product that ... the eye of a writer at The New York ...
(Date:11/27/2014)... VogueQueen.com is making every effort to offer ... world. As the premier online supplier of elegant special ... release a huge selection of sexy prom dresses today. ... also providing many beautiful styles in its product line. ... discounted prices. , “VogueQueen.com hopes to provide a truly ...
(Date:11/27/2014)... Dallas, Texas (PRWEB) November 27, 2014 ... research report on Global Insulin industry. For an ... including definition, classification, application, industry chain structure, industry ... report on global Insulin industry covers information ... manufacturing process, product cost structure and much more. ...
Breaking Medicine News(10 mins):Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3
... cancer gene can be turned on and off , MONDAY, ... becomes a bully while his peers are becoming thoughtful and ... their development that allows them to grow into cancerous tissue, ... researchers have identified a chemical process that turns off the ...
... of ... Fruit, ORLANDO, Fla., Jan. 7 ... drink healthier, adding Sun Shower(TM) 100%,Nectarine Juices into a diet may be the ... of Sun Shower(TM) Nectarine Juices are,tremendous," said Chris New, founder, chairman and CEO ...
... DAVID,S, Bermuda, Jan. 7 Warner Chilcott,Limited (Nasdaq: ... present at the 26th,Annual JPMorgan Healthcare Conference on ... Time. Presenting for Warner Chilcott will be Paul,Herendeen, ... Warner Chilcott,s presentation will be webcast live for ...
... in Spanish . , A group of scientists ... and Molecular Biology at Universitat Autnoma de Barcelona, has published ... large quantities only in lung cancers, particularly those caused by ... not yet developed and lesions are precancerous. Thus this molecule ...
... trend, but reasons aren,t clear , , MONDAY, Jan. 7 (HealthDay ... risk of prostate cancer compared to those who forego the ... looked at all men born in Denmark between 1935 and ... lower incidence of prostate cancer than fathers did. , The ...
... 7 CoolTouch Inc., a pioneering,manufacturer of medical lasers, ... an additional 510(K) clearance from the U.S. Food,and Drug ... laser is designed to ablate fat in areas such ... of conventional liposuction in larger areas,such as the abdomen ...
Cached Medicine News:Health News:Some Immature Brain Cells May Promote Tumors 2Health News:Start Your Day the Sun Shower(TM) Way 2Health News:UAB research could improve the prognosis and treatment of lung cancer 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 3Health News:CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis 2
... of controlled compression and cold, the Shoulder ... anatomically designed cuff provides complete shoulder coverage ... ordered with an extra long strap (12AXL) ... can be ordered as a single cuff, ...
... FUNCTIONAL ARM BRACE (FAB) was designed ... to make it useful as a ... ,Far more than an "Elbow ROM ... over forearm rotation (pronation and supination)., ...
... splint features a completely padded posterior ... designed to provide passive flexion to ... fasciitis or Achilles tendonitis. Its ... order left or right. A ...
Designed for forefoot relief and healing. This shoe has a unique wedge outsole and a soft nylon upper. We also added the hi-top upper to keep the foot held back and reduce slippage. Available in five...
Medicine Products: